Leerink Swann Upgrades Merck To Outperform

Leerink Swann has upgraded Merck (NYSE: MRK) from Market Perform to Outperform. Leerink says near-term risks are already priced into the stock and Leerink thinks the long-term risk/reward is very favorable for investors.

Leerink recommends investors use near-term liquidity to build or add to an existing position. Merck closed at $32.59 on Friday. Leerink's price target on MRK, is $38, presenting 17% upside from its current price.